Literature DB >> 25432727

Paroxysmal movement disorders.

Olga Waln1, Joseph Jankovic2.   

Abstract

Paroxysmal dyskinesias represent a group of episodic abnormal involuntary movements manifested by recurrent attacks of dystonia, chorea, athetosis, or a combination of these disorders. Paroxysmal kinesigenic dyskinesia, paroxysmal nonkinesigenic dyskinesia, paroxysmal exertion-induced dyskinesia, and paroxysmal hypnogenic dyskinesia are distinguished clinically by precipitating factors, duration and frequency of attacks, and response to medication. Primary paroxysmal dyskinesias are usually autosomal dominant genetic conditions. Secondary paroxysmal dyskinesias can be the symptoms of different neurologic and medical disorders. This review summarizes the updates on etiology, pathophysiology, genetics, clinical presentation, differential diagnosis, and treatment of paroxysmal dyskinesias and other episodic movement disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Episodic ataxia; Paroxysmal choreoathetosis; Paroxysmal dyskinesia; Paroxysmal dystonia

Mesh:

Year:  2015        PMID: 25432727     DOI: 10.1016/j.ncl.2014.09.014

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  16 in total

1.  ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.

Authors:  Jennifer R Friedman; Aurélie Méneret; Dong-Hui Chen; Oriane Trouillard; Marie Vidailhet; Wendy H Raskind; Emmanuel Roze
Journal:  Mov Disord       Date:  2015-12-21       Impact factor: 10.338

Review 2.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

Review 3.  Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors.

Authors:  S Mohammadi; M Dolatshahi; F Rahmani
Journal:  J Endocrinol Invest       Date:  2020-06-04       Impact factor: 4.256

4.  Paroxysmal Nonepileptic Events in Glut1 Deficiency.

Authors:  Joerg Klepper; Baerbel Leiendecker; Christin Eltze; Nicole Heussinger
Journal:  Mov Disord Clin Pract       Date:  2016-07-08

Review 5.  Medical treatment of dystonia.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2016-12-19

6.  A homozygous PIGN missense mutation in Soft-Coated Wheaten Terriers with a canine paroxysmal dyskinesia.

Authors:  Ana L Kolicheski; Gary S Johnson; Tendai Mhlanga-Mutangadura; Jeremy F Taylor; Robert D Schnabel; Taroh Kinoshita; Yoshiko Murakami; Dennis P O'Brien
Journal:  Neurogenetics       Date:  2016-11-28       Impact factor: 2.660

7.  Paroxysmal Dyskinesia in Border Terriers: Clinical, Epidemiological, and Genetic Investigations.

Authors:  Q E M Stassen; L L E Koskinen; F G van Steenbeek; E H Seppälä; T S Jokinen; P G M Prins; H G J Bok; M M J M Zandvliet; M Vos-Loohuis; P A J Leegwater; H Lohi
Journal:  J Vet Intern Med       Date:  2017-07       Impact factor: 3.333

Review 8.  Ataxia in children: early recognition and clinical evaluation.

Authors:  Piero Pavone; Andrea D Praticò; Vito Pavone; Riccardo Lubrano; Raffaele Falsaperla; Renata Rizzo; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2017-01-13       Impact factor: 2.638

9.  Paroxysmal Dyskinesia in Norwich Terrier Dogs.

Authors:  Luisa De Risio; Oliver P Forman; Cathryn S Mellersh; Julia Freeman
Journal:  Mov Disord Clin Pract       Date:  2016-05-19

10.  Phenotypic insights into ADCY5-associated disease.

Authors:  Florence C F Chang; Ana Westenberger; Russell C Dale; Martin Smith; Hardev S Pall; Belen Perez-Dueñas; Padraic Grattan-Smith; Robert A Ouvrier; Neil Mahant; Bernadette C Hanna; Matthew Hunter; John A Lawson; Christoph Max; Rani Sachdev; Esther Meyer; Dennis Crimmins; Donald Pryor; John G L Morris; Alex Münchau; Detelina Grozeva; Keren J Carss; Lucy Raymond; Manju A Kurian; Christine Klein; Victor S C Fung
Journal:  Mov Disord       Date:  2016-04-08       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.